GlassScriptPhysician profile
Fadi Ghrair
NPI 1619363066
$71,857.52
in general payments reported to CMS, 2019-2025
24 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $1,069 · 2021: $4,460 · 2022: $37K · 2023: $8,921 · 2024: $8,746 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Food and Beverage: $11K · Consulting Fee: $2,650 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,787.43 |
| Food and Beverage | $11,064.25 |
| Consulting Fee | $2,650.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $34,088.31 | 2021-2025 | Corevalve Evolut R, Na |
| Abbott Laboratories | $17,375.79 | 2020-2025 | Supera, Triclip, Navitor |
| Edwards Lifesciences Corporation | $9,390.47 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Penumbra, INC. | $3,540.24 | 2022-2023 | Indigo System |
| W. L. Gore & Associates, INC. | $2,480.35 | 2022-2024 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Boston Scientific Corporation | $1,387.97 | 2020-2025 | Watchman Flx, General - Structural Heart, Avvigo Guidance System |
| Medical Device Business Services, INC. | $960.80 | 2023 | Carto 3 |
| Medtronic Vascular, INC. | $347.20 | 2020 | |
| Pfizer INC. | $334.22 | 2019-2022 | |
| Cardiovascular Systems INC. | $329.33 | 2020-2023 | Diamondback Coronary |
| Abiomed | $270.58 | 2023-2025 | Impella |
| Asahi Intecc USA, INC. | $239.12 | 2021-2022 | |
| Amgen INC. | $188.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $181.97 | 2024-2025 | Camzyos |
| Chiesi USA, INC. | $132.02 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $123.48 | 2025 | |
| Shockwave Medical, INC | $121.45 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $105.18 | 2024 | Verquvo |
| Scpharmaceuticals INC. | $73.47 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $67.59 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.12 | 2024-2025 | Lifevest |
| Lantheus Medical Imaging, INC. | $24.74 | 2021 | |
| Stryker Corporation | $16.19 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $15.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Ghrair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.